Abnormal hCG levels in a patient with treated stage I seminoma: A diagnostic dilemma

Department of Radiation Oncology, St, Luke's Hospital, Dublin, Ireland.
World Journal of Surgical Oncology (Impact Factor: 1.41). 02/2008; 6(1):68. DOI: 10.1186/1477-7819-6-68
Source: PubMed


We report the case of a patient with treated Stage Ia seminoma who was found to have an elevated beta human chorionic gonadotrophin (hCG) on routine follow - up. This instigated restaging and could have lead to commencement of chemotherapy.
The patient was a bodybuilder, and following a negative metastatic work - up, admitted to injecting exogenous beta hCG. This was done to reduce withdrawal symptoms from androgen abuse. The patient remains well eight years post diagnosis.
This case highlights the need for surgical oncologists to conduct vigilant screening of young male patients with a history of testicular germ cell tumours and who may indulge in steroid abuse.

Download full-text


Available from: Noel Aherne